Squarepoint Ops LLC Puma Biotechnology, Inc. Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 75,929 shares of PBYI stock, worth $227,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares

75,929

Previous 99,247 23.49%

Holding current value

$227,027

Previous $253,000 8.7%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.42 - $3.39 $56,429 - $79,048	-23,318 Reduced 23.49%	75,929 $231,000
Q3 2024 Nov 14, 2024	BUY	$2.25 - $4.03 $62,676 - $112,259	27,856 Added 39.02%	99,247 $253,000
Q2 2024 Aug 14, 2024	BUY	$2.92 - $5.83 $31,410 - $62,713	10,757 Added 17.74%	71,391 $232,000
Q1 2024 May 15, 2024	BUY	$4.29 - $7.4 $138,292 - $238,546	32,236 Added 113.52%	60,634 $321,000
Q4 2023 Feb 14, 2024	SELL	$2.23 - $4.49 $139,573 - $281,024	-62,589 Reduced 68.79%	28,398 $122,000
Q2 2023 Aug 14, 2023	BUY	$2.6 - $3.58 $192,756 - $265,410	74,137 Added 439.98%	90,987 $321,000
Q1 2023 May 15, 2023	SELL	$2.21 - $4.82 $2,305 - $5,027	-1,043 Reduced 5.83%	16,850 $52,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $37,933 - $90,896	17,893 New	17,893 $75,000
Q1 2022 May 16, 2022	SELL	$2.13 - $3.24 $81,368 - $123,771	-38,201 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $174,294 - $402,406	-61,156 Reduced 61.55%	38,201 $116,000
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $148,717 - $210,627	22,431 Added 29.16%	99,357 $696,000
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $334,289 - $431,821	37,226 Added 93.77%	76,926 $706,000
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $135,334 - $196,653	-14,428 Reduced 26.66%	39,700 $386,000
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $267,826 - $417,575	34,425 Added 174.72%	54,128 $555,000
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $28,927 - $33,921	3,045 Added 18.28%	19,703 $199,000
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $116,772 - $220,551	16,658 New	16,658 $174,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $821,254 - $1.91 Million	-130,773 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $254,501 - $420,122	-39,154 Reduced 23.04%	130,773 $1.14 Million
Q3 2019 Nov 14, 2019	SELL	$8.75 - $12.85 $159,468 - $234,191	-18,225 Reduced 9.69%	169,927 $1.83 Million
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $1.95 Million - $5.68 Million	158,862 Added 542.38%	188,152 $2.39 Million
Q1 2019 May 15, 2019	SELL	$20.77 - $42.37 $30,635 - $62,495	-1,475 Reduced 4.79%	29,290 $1.14 Million
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $189,179 - $440,194	-9,426 Reduced 23.45%	30,765 $626,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $1.66 Million - $2.41 Million	40,191 New	40,191 $1.84 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $634,372 - $1.05 Million	-10,626 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $183,476 - $258,939	1,955 Added 22.55%	10,626 $1.05 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $624,312 - $1.04 Million	8,671	8,671 $1.04 Million

Others Institutions Holding PBYI

# of Institutions

110

Shares Held

28.3M

Call Options Held

27.9K

Put Options Held

3.4K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $136M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Puma Biotechnology, Inc. Transaction History